The European Commission has presented a European strategy to accelerate the development, manufacture and deployment of vaccines against COVID-19. An effective and safe vaccine against the virus is our best bet for a permanent solution to the pandemic. The Commission will support efforts to accelerate the development and availability of safe and effective vaccines within […]
Read More
Statistics: COVID-19 evolution in Eastern Mediterranean – May
Infections by country As of 29 May 2020, the countries with the highest number of registered cases are Iran (1,721,926 cases), Saudi Arabia (438,238), Pakistan (141,779), Qatar (89,976) and the United Arab Emirates (86,943). However, in terms of population, the countries with the highest number of infections are Qatar (2342 cases per 100,000 population), Kuwait […]
Read More
First COVID-19 treatment recommended for EU authorization
EMA’s human medicines committee (CHMP) has recommended granting conditional marketing authorisation to Veklury (remdesivir) for the treatment of COVID-19 in adults and adolescents from 12 years of age with pneumonia who require supplemental oxygen Remdesivir is the first medicine against COVID-19 to be recommended for authorisation in the EU. Data on remdesivir were assessed in […]
Read More
Statistics: COVID-19 evolution in the Western Pacific – May
Infections by country As of 29 May 2020, the countries with the most cases registered are China (84,432 cases), Singapore (41,216), the Philippines (27,238), Japan (17,530) and South Korea (12,198). However, if we look at the number of inhabitants, the countries with the most infections are Singapore (with 712 cases per 100,000 inhabitants), Australia (36), […]
Read More
Global regulators discuss data requirements for phase 3 trials of COVID-19 vaccines
Under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA), international regulators discussed COVID-19 vaccine development and the necessary evidence required for regulatory decision-making at the second regulatory workshop on COVID-19 vaccines. The meeting was jointly organised by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) on 22 June […]
Read MoreEIB to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing
The European Investment Bank (EIB) and BioNTech (Nasdaq: BNTX, BioNTech) have concluded a €100 million debt financing agreement to support the development of BNT162, the company’s COVID-19 vaccine programme. The deal will also allow the company to expand its manufacturing capacity in order to supply the vaccine fast worldwide in response to the pandemic. This […]
Read More
Regulatory flexibility to ensure availability of veterinary medicines during COVID-19
The European Commission, EMA and the Coordination Group for Mutual Recognition and Decentralised Procedure – Veterinary (CMDv) have issued guidance on adaptations to the regulatory framework to companies that develop, manufacture and distribute veterinary medicines in order to address some of the constraints posed by the COVID-19 pandemic. According to the jointly developed question-and-answer (Q&A) document, regulatory rules […]
Read MoreCoronavirus Global Response: €7.4 billion raised for universal access to vaccines
The Commission has registered €7.4 billion, equivalent to $8 billion, in pledges from donors worldwide during the Coronavirus Global Response pledging event. This includes a pledge of €1.4 billion by the Commission. This almost reaches the initial target of €7.5 billion and is a solid starting point for the worldwide pledging marathon, which begins today. The […]
Read More